MIRO1 controls energy production and proliferation of vascular smooth muscle cells

Abstract Background The outer mitochondrial Rho GTPase 1, MIRO1, mediates mitochondrial motility within cells, but implications for vascular smooth muscle cell (VSMC) physiology and its roles in vascular diseases, such as neointima formation following vascular injury are widely unknown. Methods Carotid ligation was performed in an in vivo model of selective Miro1 deletion in smooth muscle cells. VSMC proliferation during the cell cycle and molecular mechanisms of smooth muscle cell proliferation were explored in cultured aortic VSMCs by imaging mitochondrial positioning and cristae structure and assessing the effects on ATP production, metabolic function and interactions with components of the electron transport chain (ETC). MIRO1 expression was analyzed in human coronary arteries, and its function was assessed via knockdown in human coronary artery VSMCs. Results Results revealed strong MIRO1 expression in VSMCs within human atherosclerotic plaques. MIRO1 facilitated VSMC proliferation and neointima formation by regulating mitochondrial positioning and PDGF-stimulated ATP production and respiration, critical for cell-cycle progression at G1/S. Deletion of Miro1 disrupted mitochondrial cristae structure, diminished ETC complex I activity, and impaired super complex formation. Notably, restoring MIRO1 function with a mutant lacking EF hands, which are essential for mitochondrial mobility, only partially rescued these effects. MIRO1 knockdown in human coronary artery VSMCs confirmed its pivotal role in mitochondrial function and VSMC proliferation. Conclusions This study highlights two key mechanisms by which MIRO1 regulates VSMC proliferation. First, it maintains ATP synthesis by preserving mitochondrial cristae integrity. Second, its Ca2+-dependent EF hands enable ATP-dependent mitochondrial positioning. By linking mitochondrial motility and energy production to VSMC physiology, these findings position MIRO1 as a critical regulator of vascular remodeling and a potential target for therapeutic interventions.

Authors

Institutions

Publication Details

Published
2025-08-22
DOI
https://doi.org/10.7554/elife.107983.1
Citations
1
Primary Topic
Congenital heart defects research
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MIRO1 controls energy production and proliferation of vascular smooth muscle cells

Kamal Rahmouni, Chantal Allamargot, Isabella M. Grumbach, Colleen S. Stein et al.
1 citations
Congenital heart defects research
0.81
article

MIRO1 controls energy production and proliferation of vascular smooth muscle cells

Kamal Rahmouni, Chantal Allamargot, Isabella M. Grumbach, Colleen S. Stein, William H. Thiel, Jennifer Streeter, Benney T. Endoni, Lan Qian, Olha M. Koval, Ryan L. Boudreau, Denise Juhr, Deng‐Fu Guo, Li-Hsien Lin
article en
1 citations

Abstract

Abstract Background The outer mitochondrial Rho GTPase 1, MIRO1, mediates mitochondrial motility within cells, but implications for vascular smooth muscle cell (VSMC) physiology and its roles in vascular diseases, such as neointima formation following vascular injury are widely unknown. Methods Carotid ligation was performed in an in vivo model of selective Miro1 deletion in smooth muscle cells. VSMC proliferation during the cell cycle and molecular mechanisms of smooth muscle cell proliferation were explored in cultured aortic VSMCs by imaging mitochondrial positioning and cristae structure and assessing the effects on ATP production, metabolic function and interactions with components of the electron transport chain (ETC). MIRO1 expression was analyzed in human coronary arteries, and its function was assessed via knockdown in human coronary artery VSMCs. Results Results revealed strong MIRO1 expression in VSMCs within human atherosclerotic plaques. MIRO1 facilitated VSMC proliferation and neointima formation by regulating mitochondrial positioning and PDGF-stimulated ATP production and respiration, critical for cell-cycle progression at G1/S. Deletion of Miro1 disrupted mitochondrial cristae structure, diminished ETC complex I activity, and impaired super complex formation. Notably, restoring MIRO1 function with a mutant lacking EF hands, which are essential for mitochondrial mobility, only partially rescued these effects. MIRO1 knockdown in human coronary artery VSMCs confirmed its pivotal role in mitochondrial function and VSMC proliferation. Conclusions This study highlights two key mechanisms by which MIRO1 regulates VSMC proliferation. First, it maintains ATP synthesis by preserving mitochondrial cristae integrity. Second, its Ca2+-dependent EF hands enable ATP-dependent mitochondrial positioning. By linking mitochondrial motility and energy production to VSMC physiology, these findings position MIRO1 as a critical regulator of vascular remodeling and a potential target for therapeutic interventions.

University of Iowa (US), ABB (United States) (US), Onco Lille (FR)
U.S. Department of Veterans Affairs, American Heart Association, National Institutes of Health
Openalex Percentile: Top 24%
Congenital heart defects research
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.